Contraceptin T (Suppositories) Instructions for Use

Marketing Authorization Holder

Nizhpharm JSC (Russia)

ATC Code

G02BB (Intravaginal contraceptives)

Active Substances

Boric acid (Ph.Eur. European Pharmacopoeia)

Oxyquinoline sulfate (USAN United States Adopted Name)

Tannic acid (Ph.Eur. European Pharmacopoeia)

Dosage Form

Contraceptin T

Vaginal suppositories 30 mg+300 mg+60 mg: 10 pcs.

Dosage Form, Packaging, and Composition

5 pcs. – contour cell packs (2) – cardboard packs.

Clinical-Pharmacological Group

Vaginal contraceptive with spermicidal action

Pharmacotherapeutic Group

Contraceptive agent for topical application

Pharmacological Action

A combined contraceptive drug for local action. It also has an antiseptic effect.

Indications

Use this product for the prevention of pregnancy as a vaginal spermicidal agent.

• Employ as a primary method of contraception.
• Use as a supplementary method to enhance the reliability of barrier contraceptives such as condoms or diaphragms.

ICD codes

Dosage Regimen

Administer one suppository deeply into the vagina at least 15 minutes before each sexual intercourse to allow for proper dispersion.

Insert a new suppository for every subsequent act of intercourse. The spermicidal effect is not permanent and diminishes over time.

Adverse Reactions

Be aware of potential local reactions at the application site, including itching, burning, redness, or swelling of the vaginal mucosa and vulva.

Discontinue use immediately and consult a physician if you experience signs of a local allergic reaction or if symptoms persist or worsen.

Drug Interactions

No specific drug interactions with systemic medications have been formally established for this topical vaginal product.

Avoid concurrent intravaginal use with other topical vaginal preparations, such as creams, gels, or other suppositories, as they may interfere with the distribution and spermicidal efficacy of the product.

Contraindications

Do not use this product under the following conditions.

• Known hypersensitivity or allergy to any of the active substances (oxyquinoline sulfate, boric acid, tannic acid) or any other component of the suppository.
• The presence of acute or chronic inflammatory diseases of the vagina and cervix, or any signs of genital tissue erosion or damage.
• Use is prohibited in cases of suspected pregnancy or during confirmed pregnancy.

Overdose

Overdose from vaginal use is unlikely; however, excessive or very frequent application may increase the risk and severity of local adverse reactions, such as intense irritation or chemical burns to the vaginal mucosa.

In case of accidental ingestion, which is particularly dangerous due to the high toxicity of boric acid when absorbed systemically, seek immediate medical attention. Symptoms of boric acid poisoning may include abdominal pain, vomiting, diarrhea, rash, headache, and in severe cases, seizures and kidney failure.

Storage Conditions

In a dry place protected from light and out of reach of children at a temperature not exceeding 20°C (68°F).

Shelf Life

Shelf life – 3 years.

Dispensing Status

Over-the-counter.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.